These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Differential effects of vincristine and phenytoin on the proliferation, migration, and invasion of human glioma cell lines. Tonn JC; Haugland HK; Saraste J; Roosen K; Laerum OD J Neurosurg; 1995 Jun; 82(6):1035-43. PubMed ID: 7539063 [TBL] [Abstract][Full Text] [Related]
11. Effect of alkyl-lysophospholipid on glioblastoma cell invasion into fetal rat brain tissue in vitro. Engebraaten O; Bjerkvig R; Berens ME Cancer Res; 1991 Mar; 51(6):1713-9. PubMed ID: 1998962 [TBL] [Abstract][Full Text] [Related]
12. Migration, proliferation, and invasion of human glioma cells following treatment with simvastatin. Gliemroth J; Zulewski H; Arnold H; Terzis AJ Neurosurg Rev; 2003 May; 26(2):117-24. PubMed ID: 12962298 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity of trimetrexate against antifolate-resistant human T-cell leukemia cell lines developed in oxidized or reduced folate. Miyachi H; Takemura Y; Kobayashi H; Ando Y Jpn J Cancer Res; 1997 Sep; 88(9):900-6. PubMed ID: 9369939 [TBL] [Abstract][Full Text] [Related]
14. Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro. Tonn JC; Kerkau S; Hanke A; Bouterfa H; Mueller JG; Wagner S; Vince GH; Roosen K Int J Cancer; 1999 Mar; 80(5):764-72. PubMed ID: 10048980 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor and laminin receptors contribute to migratory and invasive properties of gliomas. Tysnes BB; Haugland HK; Bjerkvig R Invasion Metastasis; 1997; 17(5):270-80. PubMed ID: 9876221 [TBL] [Abstract][Full Text] [Related]
16. Release of replication-deficient retroviruses from a packaging cell line: interaction with glioma tumor spheroids in vitro. Thorsen F; Visted T; Lehtolainen P; Ylä-Herttuala S; Bjerkvig R Int J Cancer; 1997 May; 71(5):874-80. PubMed ID: 9180159 [TBL] [Abstract][Full Text] [Related]
17. Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein. Westerhof GR; Rijnboutt S; Schornagel JH; Pinedo HM; Peters GJ; Jansen G Cancer Res; 1995 Sep; 55(17):3795-802. PubMed ID: 7641196 [TBL] [Abstract][Full Text] [Related]
18. Loss of folylpoly-gamma-glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation-dependent novel antifolates in multiple human leukemia sublines. Liani E; Rothem L; Bunni MA; Smith CA; Jansen G; Assaraf YG Int J Cancer; 2003 Feb; 103(5):587-99. PubMed ID: 12494465 [TBL] [Abstract][Full Text] [Related]
19. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance. Jansen G; Westerhof GR; Kathmann I; Rademaker BC; Rijksen G; Schornagel JH Cancer Res; 1989 May; 49(9):2455-9. PubMed ID: 2706633 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of novel antifolates against human squamous carcinoma cell lines of the head and neck with inherent resistance to methotrexate. van der Laan BF; Jansen G; Kathmann GA; Westerhof GR; Schornagel JH; Hordijk GJ Int J Cancer; 1992 Jul; 51(6):909-14. PubMed ID: 1639538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]